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With the upcoming NHSN release, the Dialysis Event form and Outpatient Dialysis Center Practices     
Survey have been modified in response to user feedback: 
 
Dialysis Event Form 
 
Users will be able to: 
 Indicate if the patient was admitted/readmitted to their dialysis facility on the dialysis event date 
 Specify whether the “other access device” is a catheter-graft hybrid  
 Make general comments specific to the “Risk Factors” section, such as the type of material used for a 
patient’s graft or clarification if the patient has more than one vascular access device of the same type 
 
  New 2013 Outpatient Dialysis Center Practices Survey 
 
A revised version of the Outpatient Dialysis Center Practices Survey has been developed for 2013!          
It will be available for printing from the NHSN Dialysis Event Homepage                                             
(http://www.cdc.gov/nhsn/psc_da_de.html) before January 1, 2013. The survey includes several   
questions about staff and patients who are present during the first week of January, so users are 
strongly encouraged to complete the new survey on paper during this time. 
 
This new survey cannot be entered into NHSN until after the next NHSN version release, which is     
presently scheduled for mid-February. Beginning January 1, upon login users will be prompted to enter  
a 2013 survey.  We recommend that you use the new form to collect the data on paper, but wait until 
after mid-February to enter the data online into NHSN. 
continue to page 2 
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Changes to the Outpatient Dialysis Center Practices Survey for 2013 will be: 
 Several questions have been clarified to ensure everyone interprets the question in the same way (if in doubt, you can always 
email nhsn@cdc.gov with “Dialysis Event” in the subject line for clarification). 
 A few new questions have been added to keep up-to-date with current practices. Examples  include: 
Does your facility use hemodialysis machine Waste Handling Option (WHO) ports? 
Do technicians administer any IV medications (e.g., heparin, saline)? 
Does your facility participate in any national or regional infection prevention initiatives? 
Do you follow CDC-recommended Core interventions to prevent bloodstream infections in hemodialysis patients? 
 
We will notify you via email when revised forms are available for download/printing from  the NHSN Dialysis Event Homepage 
(http://www.cdc.gov/nhsn/psc_da_de.html).  Please contact nhsn@cdc.gov with questions and include “Dialysis Event” or 
“Dialysis Survey” in the subject line. 
Stakeholder Group and Subject Matter Expert Workgroup 
In a new effort to obtain input from collaborating organizations and participating transfusion services, the CDC has established a 
Stakeholder Group and a Subject Matter Expert (SME) workgroup for the Hemovigilance Module. The Stakeholder Group has been 
convened to foster collaboration with organizations that might benefit from Hemovigilance Module data. The SME workgroup is   
responsible for proposing modifications to improve participation and data quality, including changes to simplify requirements.  
 
Training Material 
The Incident Reporting training slides have been updated and a new Quick Reference Guide, Biovigilance Component Alerts, has 
been added. We recommend all users review the updated training slides as well as the new reference guide. To view the new     
training material, please visit the Biovigilance Component website at http://www.cdc.gov/nhsn/bio.html. 
 
AABB Audioconference 
The Biovigilance Component team will be participating in AABB’s Audioconference Series on Wednesday, December 19, 2012. The 
Audioconference will include a demonstration of the NHSN Hemovigilance Module. For more information, please visit AABB’s web-
site at www.aabb.org.  
 
March 2013 NHSN Hemovigilance Module Training Workshop 
There will be a free, comprehensive training workshop on the NHSN Hemovigilance Module in Atlanta on March 6th, 2013, at the 
CDC. The workshop will cover surveillance requirements, adverse reaction and incident definitions, and a hands-on demonstration  
of the NHSN application and analysis features. Travel will be sponsored for one attendee per participating NHSN facility until space 
is filled. For more information, please visit http://events.SignUp4.com/NHSNHemoModuleTrainWorkshop.  
Feel free to send your questions and feedback to nhsn@cdc.gov with “Hemovigilance” in the subject line. 
 
NHSN Dialysis Event Surveillance 
Hemovigilance Module Update 
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The Healthcare Personnel (HCP) Influenza Vaccination Summary reporting option is available for use in NHSN. The protocol, data 
collection forms, training slides, operational guidance, and FAQs are now posted on the HPS Component Vaccination Module page: 
http://www.cdc.gov/nhsn/hps_Vacc.html. Acute care facilities participating in the CMS Hospital Inpatient Quality Reporting (IQR) 
Program are required to report HCP influenza vaccination summary data beginning January 1, 2013. However, for the 2012-2013 
influenza season, acute care hospitals can submit data for the entire influenza vaccination season to NHSN, and CMS will accept 
voluntarily submitted data for vaccinations given prior to January 1, 2013, even though submission of these particular data is not 
required by the CMS rule.  
Acute care facilities can report HCP influenza vaccination summary data from October 1 (or when the vaccine became available) 
through March 31, which includes all influenza vaccinations administered during the influenza season at the facility or elsewhere, 
medical contraindications, and declinations to influenza vaccination. Users must also report associated denominator data for HCP 
physically working in the acute care hospital for at least 30 working days between October 1 and March 31 of the influenza season, 
regardless of clinical responsibility or patient contact.  Data must be reported  separately for employees, licensed independent   
practitioners, and adult students/trainees and volunteers. Reporting summary data for other contract personnel is optional at this 
time.  
CDC conducted five live training webinars on the HCP Vaccination Module in October and November 2012. Participants learned 
about NHSN requirements for reporting healthcare personnel influenza vaccination summary data. The PowerPoint presentation 
slides and re-casts of these webinars are available for viewing at: http://www2.cdc.gov/vaccines/ed/nhsn/. Please note that the 
content of each webinar is the same. For questions related to the HCP influenza vaccination summary reporting, please e-mail 








Healthcare Personnel (HCP) Influenza Vaccination Summary 
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There are many changes, revisions, and updates for NHSN in the next release planned for February 16, 2013.  Although these 
changes will not be implemented in the NHSN application until this release, users are expected to follow all updated guidance,  
definitions, rules, and criteria as of January 1, 2013.  The improvements are highlighted below, but should be reviewed by NHSN 
users in detail in the NHSN protocols, which will all be updated and posted to the NHSN website before December 31, 2013. The 
dates posted on each of the protocols should read January 2013, in order to be considered the most up-to-date information.      
Additional guides will also be distributed to NHSN users and posted to the website as they become available. 
 Small revisions have been made to all of the Annual Facility Surveys, and any surveys associated with the Patient Safety      
Component will no longer have the option to “Copy from Previous Year”, so please be sure to use the updated and posted     
January 2013 copies of the survey forms when you collect your 2012 data, to be entered after the February 16, 2013 release 
but before March 31, 2013. 
 A new survey related to the Healthcare Personnel Influenza Vaccination Summary reporting will be available. This survey collects 
information on the facility’s influenza vaccination campaign for a specific influenza season. This survey is optional at this time, 
but is requested to be completed and will be found at http://www.cdc.gov/nhsn/hps_Vacc.html. 
 The existing NHSN Organisms Lists will all be updated and new lists will be added for printing (i.e., uropathogens and organisms 
for mucosal barrier injury reporting), so please be sure to review and download the new January 2013 NHSN Organisms Lists file 
and all of the included tabs.  This file can be found at http://www.cdc.gov/nhsn/XLS/master-organism-Com-Commensals-
Lists.xlsx.  
 Fourteen new Oncology locations will be added for use by cancer hospitals as well as general acute care facilities. Please see 
the updated January 2013 locations file for the complete updated listing of all locations, their codes and descriptions, available 
within NHSN and found at http://www.cdc.gov/nhsn/PDFs/master-locations-descriptions.pdf . 
 New “2-day calendar” rules and definitions will be added for the determination of healthcare-associated infection, device-
associated infection, location of attribution, and transfer rule. These definitions are described in detail in the updated protocols 
and key terms chapters of the Patient Safety Component Manual, the latter of which also includes examples of how to apply 
these terms. 
 New criteria will be added for the optional specification of Mucosal Barrier Injury (MBI) within the reporting of a central line-
associated bloodstream infection (CLABSI). The details of the added criteria and the organisms acceptable for this reporting can 
be found in the January 2013 updated BSI protocol. The reported MBIs will not be removed from CLABSI case counts reported 
for CMS purposes in 2013, as this reporting will not be available via CDA until 2014. 
 New Ventilator-Associated Event (VAE) reporting will be available after the February 16, 2013 release for adult patients ≥ 18 
years old. Ventilator-Associated Pneumonia (VAP) reporting “in-plan” using the PNEU criteria will no longer be available for adult 
patients beginning January 1, 2013. VAP using PNEU criteria for pediatric patients will still be available in 2013, until specific 
pediatric criteria are defined for VAE. 
 There are a number of changes being implemented to procedure and surgical site infection (SSI) reporting, so please refer to the 
updated January 2013 SSI protocol and review all details. The definition of primary closure will be revised to include procedures 
where devices remain extruding through the incision at the end of surgery. The requirement for reporting implant will be re-
moved. Follow-up for SSI surveillance will be limited to 30 days for all SSI types and operative procedures, except for a subset of 
14 procedures that will require a 90-day follow-up period for deep incisional and organ/space infections. The NHSN Principal 
Operative Procedure Category Selection lists have been revised to reflect current NHSN SSI data with the order of procedures 
updated. Data fields required for saving a record will be the same for reporting data “in-plan”, according to the Monthly Report-
ing Plan, and “off-plan”.   
 A number of features and reports will be added to the Analysis Output Options.  Annual updates will be made to the device-
associated rates. SIR analysis output will be added to the MRSA blood and C. difficile LabID event data. Reports will be added 
for new data being sent to CMS, including LTAC and IRF data, HCP influenza vaccination summary data, and MRSA blood and 
CDI LabID event data. Additional output will be available for summary antimicrobial use and biovigilance data.  A reference list 
will be provided for custom fields and labels in the Patient Safety Component. Analysis functions will be added to the Long-Term 
Care Facility Component (i.e., skilled nursing facility reporting). 
continue to page 5 
Upcoming NHSN Changes for January 1, 2013 to be Implemented into NHSN on    
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Please watch for the January 2013 updated protocols, reporting forms, and additional guidance documents to be posted to the 
NHSN website for your review and use.  All previous protocols and forms will be outdated and obsolete for reporting beginning     
January 1, 2013.  Remember that the new reporting updates will not be implemented or available within the NHSN application until 
after the next release on February 16, 2013.  Therefore, data should be collected according to the new protocols and held on paper 
copies of the new forms until data entry capability becomes available in NHSN after February 16, 2013. 
Determining Temperature for Healthcare-associated Infection (HAI) Surveillance 
A few facilities have requested clarification on identifying appropriate patient temperatures for HAI surveillance. The issue  revolves 
around utilizing the documented temperature or some other temperature based on a facility policy. Here is an example highlighting 
the issue: 
A facility has a policy which states that documentation of patient temperature will include both the numeric reading and the route of 
measurement, e.g. 37.7°C (axillary).  The facility’s policy further states that for temperatures collected via the axillary and tympanic 
routes, that 0.5°C should be added to the measurement when used for clinical decision making. In the example cited, the          
temperature utilized for clinical decision making is 38.2°C although the temperature documented in the chart is 37.7°C (axillary). 
Which temperature should be utilized when applying the NHSN HAI criteria?   
For now, facilities should utilize the temperature used for clinical decision making for its HAI surveillance as well. In the  example 
provided, 38.2°C would be utilized for HAI surveillance. This will require that Infection Preventionists are aware of their facility’s  
temperature policy. Furthermore, such policies should be available to share with outside agencies which may be involved in         
validation of the facility’s HAI data. 
This issue will be considered by the Surveillance Working Group of the Healthcare Infection Control Practices Advisory  Committee. 
The final determination will be communicated to NHSN users. 
Last month, we sent an email to all Patient Safety Component participants with location mapping instructions for 2013. Note that 
beginning in January 2013, hospitals that participate in CMS’s Hospital Inpatient Quality Reporting (IQR) Program will be required to 
report MRSA bacteremia LabID Events and C. difficile LabID Events to NHSN, overall facility-wide. This will require that ALL inpatient 
hospital locations be individually mapped in NHSN, in accordance with our updated guidance. 
As a reminder, we ask that you carefully review these instructions on mapping all of your hospital inpatient locations in preparation 
for 2013 reporting. This document includes important information about the use of “virtual” locations and mixed acuity locations. 
Also in this document, you’ll find updated clarification on the 80% rule, including expansion of the medical/surgical definition       
percentages. This document is available at: http://www.cdc.gov/nhsn/PDFs/psc/MappingPatientCareLocations.pdf and will be   
incorporated into the CDC Locations and Descriptions chapter of the Patient Safety Component Manual. 
If your facility participates in more than one NHSN component, please discuss any potential changes in location mapping with the 
primary contact of each component, as locations may already be mapped and currently be in use by other NHSN component users 
in your facility. 
Patient Safety 
Reminder: CMS Reporting Requirements for MRSA Blood and C. difficile LabID Events 
are to Begin  On January 1, 2013 
Instructions for Mapping Patient Care Locations in NHSN 
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 Having trouble importing CDA zip files? Contact your vendor for assistance to start. If they are unable to identify any issues,   
contact us at nhsncda@cdc.gov for additional troubleshooting. Always be sure to send along your PDF error report – on the 
screen in NHSN that tells you that the import failed, click the button labeled “Error Report” at the bottom of the screen. A new 
PDF window will be displayed with additional error information. Save that PDF and attach it to your email. 
 You can now provide your vendor with a list of all of your NHSN location codes and mappings more easily. In the NHSN location 
manager (click on Facility > Locations in the navigation bar), there is a button labeled “Export Location List.”  Click on that     
button to export all of your locations and their mappings out of NHSN into any of a variety of formats, including Excel. 
 More facilities are coming on-line as early adopters of the Antimicrobial Use Option in the NHSN Antimicrobial Use and           
Resistance Module. Data are only able to be reported to the AU Option via CDA, and users uploading CDAs must have            
administrative rights. If your infectious disease pharmacists approach you with interest in reporting AU data, note that they will 
need to have administrative rights - or you will need to have a user with administrative rights upload AU data for them. In early 
2013, NHSN will be updated to have a new role that will allow pharmacists to have rights to upload data for the AU Option only. 
 
 





Q1. How do I determine which location to attribute a CDI LabID Event? 
Answer: Location attribution is based solely on where the patient is assigned when the specimen is collected. There are no subjec-
tive decisions allowed for location attribution for LabID event reporting. The transfer rule does not apply for LabID Events.   
Q2. Can I enter a CDI LabID Event for a toxin-positive stool specimen that was collected in the Emergency Department if the patient 
is subsequently admitted to an inpatient location? 
Answer: If a specimen collected in the emergency department is positive for CDI, and the patient it is collected from is admitted to 
the facility on the SAME date into an inpatient location that is monitoring LabID events for CDI, then that specimen can be reported 
as the first specimen for the patient in that ADMITTING INPATIENT LOCATION. 
Q3. How will NHSN categorize a CDI LabID Event if the patient was symptomatic on admission, but the toxin-positive stool specimen 
was not collected until day 4 of admission? 
Answer: NHSN will categorize the event as healthcare facility-onset (HO) since the first positive stool specimen was collected after 3 
days of admission (on or after day 4). LabID Event categorizations of HO and CO are based on date of admission to the facility and 
specimen collection date, and do not take into consideration signs/symptoms. 
Q4. What locations should be excluded from denominator data for CDI LabID Event Reporting?   
Answer: NICU, SCN and Well-baby locations, including babies in the LDRP locations.  
CDA Corner: Fall 2012 
Website Redesign Announcement 
C. difficile LabID Q & A   
 














NHSN Enrollment Update (as of December 1, 
2012): 
5,227     Hospitals (this includes 504 Long-Term 
 Acute Care Hospitals and 249 Free-
 standing Inpatient Rehabilitation               
 Facilities) 
5,778 Outpatient Hemodialysis 
251         Ambulatory Surgery Centers (ASCs) 
63           Long-term Care Facilities 
11,319   Healthcare Facilities Enrolled 
The Centers  for D isease Control  and Prevention 
(CDC)  
MS-A24 
1600 Clifton Rd 
Atlanta, GA 30333  
Email: nhsn@cdc.gov 
CDC's NHSN Web site:  www.cdc.gov/nhsn 
 
 
The National Healthcare Safety Network (NHSN) is a voluntary, secure,  Internet-based  surveillance    
system that integrates patient and healthcare personnel safety surveillance systems managed by the  
Division of Healthcare Quality  Promotion (DHQP) at CDC. 
During 2008, enrollment in NHSN was opened to all types of healthcare  facilities in the United States, 
including acute care hospitals, long-term acute care hospitals, psychiatric  hospitals, rehabilitation       
hospitals,  outpatient  dialysis centers, ambulatory surgery centers, and long term care facilities. 
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Teresa Horan is retiring from the Centers for Disease Control and Prevention (CDC) after 
over 28 years of  illustrious service in the agency’s Division of Healthcare Quality          
Promotion and its predecessor units. Teresa joined the CDC and the Hospital Infections 
Program in 1984, working first as Coordinator of the National Nosocomial Infections    
Surveillance (NNIS) System and subsequently leading the transition from NNIS to the   
National Healthcare Safety Network (NHSN), which was launched in 2005.  Her superb 
contributions to surveillance and prevention of healthcare-associated infection are       
singularly important to the field and an inspiration to her CDC colleagues, frontline       
infection preventionists, and other professionals working to improve patient safety 
throughout the United States and internationally.   
Teresa’s contributions to HAI surveillance are legion. In her role NNIS coordinator she 
taught, led national workshops, and provided consultations for hundreds of infection   
control professionals (now known as infection preventionists). She prepared and maintained pivotally important NNIS surveillance 
manuals, each of which integrated cutting-edge information about HAIs and their epidemiology with best practices for targeted HAI 
case finding, data analysis, and application of results to prevention. She conducted numerous analyses using HAI surveillance data, 
and during her CDC career she published over 50 scientific articles and commentaries, many of which are among the most-cited 
publications in the field.  She also was a principal author of the chapter on HAI surveillance for numerous editions of the leading 
texts on healthcare epidemiology.    
She was instrumental in writing the 1999 Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines for         
preventing surgical site infections and was a major contributor to the 2005 HICPAC guidance on public reporting of HAIs. As her   
stature in infection prevention grew nationally and internationally, she served as consultant to Ministries of Health, Schools of    
Public Health, and professional organizations in more than a dozen countries.  
At CDC, she led the transition from the DOS-based NNIS to its web-based successor NHSN, which was launched seven years ago 
and now includes participation by healthcare facilities in all 50 states.  In recent years, she has led educational and data quality          
assurance programs for NHSN, bringing to bear her exceptional subject matter expertise and her unparalleled experience with HAI 
surveillance.   
Teresa has served with distinction in the U.S. Public Health Service Commissioned Corps, achieving the rank of Captain, volunteer-
ing for numerous Commissioned Corps deployments, and receiving numerous awards for her service.  Her illustrious career and         
enormous contributions are highly praised by her professional peers.  In 2006, she was awarded the Carole DeMille Achievement 
Award by the Association for Professionals in Infection Control and Epidemiology (APIC), the organization’s highest honor. Her                 
commendation noted that she had inspired professionals around the world to strive for better monitoring, prevention, and            
management of HAIs. In 2012, Teresa received the prestigious William G. Watson, Jr., Medal of Excellence from CDC’s National    
Center for Emerging and Zoonotic Infectious Diseases for her extraordinary career achievements. 
More than any other individual, Teresa has shaped HAI surveillance in the United States for nearly three decades. Her efforts 
amount to a uniquely important contribution, the consequences of which are that HAI surveillance serves as a model of how to   
collect,  analyze, and apply data in ways that prevent adverse events in healthcare. Her accomplishments will yield benefits for pa-
tients and public health for years to come.           
 
Teresa Horan Set to Retire from CDC 
